B cell development I Flashcards

1
Q

Where do B cells develop and where do they engage foreign Ag?

A

develop -> bone marrow
engage -> peripheral lymphoid organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are different B cell stages be distinguished?

A
  • rearrangement status of heavy and light chain genes
  • cell surface markers: surface Ig (BCR), others (lamda5, VpreB, BAFFR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some defining features of a pro B cell?

A
  • committed to becoming a B cell
  • turns on B cell genes, including Rag-1/2, TFs for B cell genes
  • turn off/repress genes important for other lineages
  • starts to rearrange Ig heavy chain gene
  • receive signals from bone marrow stromal cells that promote proliferation and further development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some consequences of lacking Rag-1/2?

A
  • B cells don’t get past the pro-B cell stage of development
  • T cell development is also blocked at an early stage
  • SCID phenotype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does SCID stand for?

A

Severe combined immunodeficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is SCIDs?

A
  • defect in B and T cell function
  • severely impaired adaptive immunity
  • severely immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can SCIDs be treated?

A
  • live in a sterile environment (bubble boy)
  • bone marrow transplant -> bone marrow from healthy person can fix the patient’s bone marrow
  • gene therapy -> if we know the defect, introduction of a functional gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What makes mice a good model system to study human biology?

A
  • mammal
  • similar genetic diversity -> most human genes have analogous mouse genes
  • similar physiology
  • genetic abnormalities that cause disease are similar to mouse, including immunological disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How was Rag deficiency studied in the mouse? Name the techniques and how the data was represented.

A

Generate mice with knock-out of Rag-1 gene; used flow cytrometry to identify cell populations; represented on a dot plot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the functions of the green PMT, red PMT, side scatter, and forward scatter in flow cytrometry

A

green PMT = detect cells that have green Abs
red PMT = detect cells that have red Abs
side scatter = granularity (remove debris)
forward scatter = cell size (ensures single cell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the purpose of flow cytrometry?

A
  • technique to measure the expression of specific proteins on the surface (or inside) of individual cells
  • cells strained with fluorescently labeled Ab.s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the two graphical representations of flow cytrometry data

A
  1. histogram plot
  2. dot plot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When SCIDs was modeled in the mouse, what markers were used to identify mature T cells and what markers were used to identify mature B cells

A

T cells:
- CD4
- CD8

B cells:
-B220 (B cell phosphotase; CD45R)
- IgM and IgD (IgD is a marker of a mature B cell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When SCIDs was modeled in the mouse, where were the cells isolated from and why?

A

where: spleen
why: this is where a large population of mature B and T cells are found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When SCIDs was modeled in the mouse, and Rag-1 was knocked-out, what was the major finding?

A

No mature B and T cells in the spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some defining features of a pre-B cell?

A
  • characterized by rearranged heavy chain
  • two sub-types (early/large; late/small)
  • heavy chain expressed and pairs with surrogate light chain to for the pre-B cell R (pre-BCR)
  • several rounds of proliferation at this stage -> daughter cells will have the same heavy chain, but will go on to have different light chains
  • transcription of heavy chain is linked to VDJ recombination
17
Q

What are some features of the IgH locus?

A
  1. contains promoters upstream of each V segment
    - binds RNAP II
    - sites where ts is initiated
  2. enhancer elements in intron between variable and constant regions (E(mu)) and 3’ of alpha constant region (3’(alpha)E)
    - bind TFs
  3. IgH gene is in inactive chromatin in non-B cells, including early hematopoietic progenitors
18
Q

What are some features of the IgH locus in early pro-B cells?

A
  1. chromatin becomes accessible
  2. B cell specific gene regulatory proteins are expressed and bind to enhancer elements
    - e.g. Oct-2
  3. not much transcription from V segment promoters
    - too far from enhancers
    - however VDJ recombination is underway
19
Q

What are some features of the IgH locus in pre-B cells?

A
  1. rearrangements bring enhancers closer to V segment promoters
  2. efficient transcription of heavy chain gene
20
Q

What are some features of the pre-BCR?

A
  1. rearranged heavy chain pairs with surrogate light chain
  2. surrogate light chain is the same on all pre B cells = VpreB (like V(L)) + lamda5 (like C(L)))
  3. surrogate light chain expressed by all pre-B cells
  4. VpreB has extra C-term acidic residues and lamda5 has extra N-term basic residues
  5. allows multiple pre-BCRS to self-aggregate (no ligand needed)
  6. self-aggregation of pre-BCR initiates signaling via BTK = critical development checkpoint)
21
Q

What are some features of XLA?

A
  • almost all patients are male
  • patients are hemizygous for btk mutant allele
  • females are asymptomatic carriers
22
Q

How is XLA treated?

A
  1. current therapies directed at reintroducing Ab.s rather than correcting defect in B cells
    - patients receive weekly IgG injections from many blood donors which restores humoral immunity
  2. patients are treated more liberally with antibiotics